Wintrust Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$199K Sell
763
-829
-52% -$246K 0.18% 95
2024
Q3
$513K Sell
1,592
-13,653
-90% -$4.47M 0.38% 46
2024
Q2
$4.76M Sell
15,245
-95
-0.6% -$27.9K 0.39% 48
2024
Q1
$4.36M Buy
15,340
+299
+2% +$87.5K 0.38% 50
2023
Q4
$4.33M Sell
15,041
-26,530
-64% -$7.23M 0.42% 47
2023
Q3
$11.2M Sell
41,571
-141
-0.3% -$35.2K 1.17% 15
2023
Q2
$9.23M Sell
41,712
-12,311
-23% -$2.86M 0.93% 18
2023
Q1
$13M Sell
54,023
-3,542
-6% -$869K 1.66% 11
2022
Q4
$14.9M Buy
57,565
+39,021
+210% +$10.5M 1.94% 9
2022
Q3
$4.12M Sell
18,544
-2,021
-10% -$490K 0.52% 40
2022
Q2
$4.74M Sell
20,565
-2,659
-11% -$652K 0.57% 35
2022
Q1
$5.33M Sell
23,224
-1,031
-4% -$237K 0.51% 41
2021
Q4
$5.4M Buy
24,255
+4,650
+24% +$981K 0.51% 36
2021
Q3
$4.24M Buy
19,605
+10,996
+128% +$2.53M 0.57% 30
2021
Q2
$2.09M Buy
8,609
+1,288
+18% +$317K 0.21% 96
2021
Q1
$1.82M Buy
+7,321
New +$1.75M 0.19% 108
2020
Q4
Sell
-1,300
Closed -$270K 186
2020
Q3
$270K Sell
1,300
-7,042
-84% -$1.74M 0.04% 281
2020
Q2
$1.93M Sell
8,342
-65
-0.8% -$14.8K 0.27% 69
2020
Q1
$1.72M Buy
8,407
+901
+12% +$197K 0.28% 68
2019
Q4
$1.74M Sell
7,506
-745
-9% -$164K 0.24% 79
2019
Q3
$1.65M Sell
8,251
-8,953
-52% -$1.72M 0.25% 76
2019
Q2
$3.28M Buy
17,204
+4,238
+33% +$759K 0.5% 39
2019
Q1
$2.66M Buy
12,966
+4,084
+46% +$780K 0.43% 49
2018
Q4
$1.83M Sell
8,882
-2,855
-24% -$557K 0.34% 58
2018
Q3
$2.54M Buy
11,737
+1,697
+17% +$334K 0.41% 44
2018
Q2
$2.1M Buy
10,040
+4,229
+73% +$748K 0.37% 49
2018
Q1
$1.16M Buy
5,811
+3,197
+122% +$587K 0.3% 69
2017
Q4
$455K Buy
2,614
+307
+13% +$54.3K 0.11% 175
2017
Q3
$430K Sell
2,307
-589
-20% -$104K 0.11% 178
2017
Q2
$499K Buy
2,896
+789
+37% +$128K 0.13% 160
2017
Q1
$346K Buy
+2,107
New +$350K 0.1% 207

Other funds holding AMGN

Wintrust Investments's AMGN Position: Q4 2024 in Review

Wintrust Investments reduced its Amgen (AMGN) stake by 52% in Q4 2024, selling an estimated $246K and leaving 763 shares worth $199K. The position accounts for 0.18% of the portfolio, ranked #95.

Wintrust Investments first reported a position in AMGN in Q1 2017 and has held it in 31 quarters since. The position peaked at $14.9M in Q4 2022. 2,856 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Wintrust Investments held 763 shares of Amgen worth $199K as of Q4 2024.
  • Wintrust Investments sold 829 Amgen shares in Q4 2024, an estimated $246K.
  • Amgen made up 0.18% of Wintrust Investments's portfolio in Q4 2024, its #95 holding.
  • Wintrust Investments first reported a position in Amgen in Q1 2017 and has held it in 31 quarters since.
  • Wintrust Investments's Amgen position peaked at $14.9M in Q4 2022.
  • 2,856 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.